7,426 Shares in Globe Life Inc. $GL Acquired by Capstone Investment Advisors LLC

Capstone Investment Advisors LLC purchased a new stake in Globe Life Inc. (NYSE:GL - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 7,426 shares of the company's stock, valued at approximately $1,327,000.

Other large investors have also recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Globe Life by 6.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company's stock valued at $1,237,000 after purchasing an additional 607 shares in the last quarter. NewEdge Advisors LLC increased its position in shares of Globe Life by 368.1% during the 1st quarter. NewEdge Advisors LLC now owns 6,806 shares of the company's stock worth $897,000 after purchasing an additional 5,352 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in Globe Life by 11.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company's stock valued at $74,161,000 after purchasing an additional 58,163 shares during the last quarter. Empowered Funds LLC bought a new position in Globe Life during the 1st quarter valued at about $428,000. Finally, Focus Partners Wealth boosted its position in Globe Life by 8.3% in the first quarter. Focus Partners Wealth now owns 8,559 shares of the company's stock valued at $1,127,000 after buying an additional 656 shares in the last quarter. 81.61% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

GL has been the topic of several research analyst reports. Morgan Stanley upped their price objective on shares of Globe Life from $181.00 to $208.00 and gave the stock an "overweight" rating in a research note on Monday, July 6th. Piper Sandler boosted their target price on Globe Life from $175.00 to $200.00 and gave the stock an "overweight" rating in a report on Wednesday, July 15th. Wells Fargo & Company increased their price target on Globe Life from $172.00 to $193.00 and gave the stock an "overweight" rating in a research report on Thursday, July 9th. JPMorgan Chase & Co. raised their price target on Globe Life from $181.00 to $201.00 and gave the company an "overweight" rating in a report on Tuesday, July 21st. Finally, Keefe, Bruyette & Woods cut their price objective on Globe Life from $192.00 to $190.00 and set an "outperform" rating for the company in a research report on Friday, July 24th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat.com, Globe Life currently has an average rating of "Moderate Buy" and an average target price of $191.67.

Insider Activity

In other news, CEO Frank M. Svoboda sold 10,000 shares of the business's stock in a transaction on Friday, June 12th. The stock was sold at an average price of $166.68, for a total transaction of $1,666,800.00. Following the completion of the sale, the chief executive officer owned 54,020 shares in the company, valued at $9,004,053.60. The trade was a 15.62% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Thomas Peter Kalmbach sold 25,650 shares of the company's stock in a transaction on Tuesday, July 28th. The shares were sold at an average price of $178.58, for a total value of $4,580,577.00. Following the transaction, the chief financial officer directly owned 50,568 shares in the company, valued at $9,030,433.44. This trade represents a 33.65% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 151,908 shares of company stock worth $27,239,981. 2.11% of the stock is owned by company insiders.

Globe Life Stock Up 0.1%

Shares of NYSE:GL opened at $175.78 on Friday. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.43. The firm has a market cap of $13.51 billion, a P/E ratio of 11.67 and a beta of 0.48. Globe Life Inc. has a 12 month low of $127.85 and a 12 month high of $191.55. The company's 50-day moving average price is $178.72 and its two-hundred day moving average price is $159.43.

Globe Life (NYSE:GL - Get Free Report) last announced its earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing analysts' consensus estimates of $3.67 by ($0.06). Globe Life had a return on equity of 20.52% and a net margin of 19.58%.The company had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same period in the prior year, the firm posted $3.05 earnings per share. The company's revenue was up 8.0% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. As a group, research analysts forecast that Globe Life Inc. will post 15.71 EPS for the current fiscal year.

Globe Life Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Monday, October 5th will be given a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 0.8%. The ex-dividend date is Monday, October 5th. Globe Life's payout ratio is 8.76%.

Globe Life announced that its Board of Directors has authorized a stock buyback program on Monday, August 10th that permits the company to buyback $2.50 billion in shares. This buyback authorization permits the company to repurchase up to 17.7% of its shares through open market purchases. Shares buyback programs are often a sign that the company's management believes its stock is undervalued.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source